A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas

PHASE2CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 27, 2015

Study Completion Date

August 31, 2016

Conditions
Basal Cell Carcinoma
Interventions
DRUG

Vismodegib

Vismodegib 150 mg hard gelatin capsule orally once daily

DRUG

Placebo

Vismodegib placebo orally once daily

Trial Locations (58)

1090

Medizinische Universität Wien; Univ.Klinik für Dermatologie, Vienna

6020

LKH Innsbruck; Universitätsklinik für Dermatologie, Innsbruck

10126

Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin

11787

Long Island Skin Cancer and Dermatologic Surgery, Smithtown

11795

Mariwalla Dermatology, West Islip

13385

Hopital Timone Adultes; Dermatologie, Marseille

14080

Hospital General Dr. Manuel Gea Gonzalez; Dermatology, México

17033

Penn State Milton S. Hershey Medical Center, Hershey

19002

Hospital General Universitario de Guadalajara; Servicio de Dermatologia, Guadalajara

21079

Chu Site Du Bocage;Dermatologie, Dijon

24105

UNI-Klinikum Campus Kiel Klinik f.Dermatologie Tagesklinik f.Dermatologie, Kiel

25123

Università di Brescia; Dipartimento di Dermatologia, Brescia

27106

The Skin Surgery Center, Winston-Salem

29414

Dermatology and Laser Center of Charleston PA, Charleston

29600

Hospital Costa Del Sol; Servicio de Dermatologia, Málaga

30322

Emory University Clinic, Atlanta

30625

Medizinische Hochschule Hannover; Klinik für Dermatologie, Allergologie und Venerologie, Hanover

32174

Advanced Derm & Cosmetic Surg, Ormond Beach

33075

Hopital Saint Andre CHU De Bordeaux; Dermatologie, Bordeaux

33324

Skin and Cancer Associates and the Center for Cosmetic Enhancement, Plantation

34295

Hopital Saint Eloi; CHU de Montpellier; Svc de Dermatologie, Montpellier

41014

Hospital General Universitario de Valencia; Servicio de oncologia, Valencia

42123

Arcispedale Santa Maria Nuova; Dermatologia, Reggio Emilia

42277

Hopital Nord ; Dermatologie, Saint-Etienne

43210

Ohio State University, Columbus

44093

Hopital Hotel Dieu Et Hme; Clinique Dermatologique, Nantes

45122

Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Essen

46009

Instituto Valenciano Oncologia; Oncologia Medica, Valencia

46032

Laser & Skin Surgery Center of Indiana, Carmel

48157

Fachklinik Hornheide; Dermatologie, Münster

50125

Ospedale IOT- Palagi Dermatologia 2, Florence

60590

Klinik Johann Wolfgang von Goethe Uni; Klinik für Dermatologie, Venerologie und Allergologie, Frankfurt

63104

Saint Louis University School of Medicine; Department of Dermatology, St Louis

63110

Washington University School of Medicine, St Louis

64046

Ch Francois Mitterrand; Medecine Oncologie, Pau

67100

Ospedale San Salvatore (ASL-01); Dip. di Dermatologia U.O.S. di Dermatologia Oncol, L’Aquila

72076

Universitätsklinikum Tübingen Universitäts-Hautklinik, Tübingen

75475

Hôpital Saint-Louis, Paris

80054

CHU Amiens - Hopital Sud, Amiens

80337

Klinikum der LMU München; Klinik und Poliklinik für Dermatologie und Allergologie, München

87042

Hopital Dupuytren; Dermatologie, Limoges

90045

Dermatology Research Associate, Los Angeles

92117

Skin Surgery Med Group, Inc, San Diego

94305

Stanford University, Palo Alto

95403

California Pacific Medical Center Research Institute, Santa Rosa

115478

Blokhin Cancer Research Center; General Oncology Department, Moscow

"FSBI Russian Oncology Research Center n.a. N. N. Blokhin of Ministry of Health of the Russian Fed", Moscow

197022

City Clinical Oncology Dispensary, Saint Petersburg

01915

Beverly Hospital;Oncology Center Pharmacy, Beverly

V5Z 4E8

UBC Department of Dermatology & Skin Sciences, Vancouver

L7N 3N2

Dermetics, Burlington

L2K 4L5

Innovaderm Research Inc., Montreal

07548

SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie, Gera

06726

Hospital General de México, Mexico City

1007 MB

VU MEDISCH CENTRUM;Afdeling Dermatologie, Amsterdam

9713 GZ

Academ Ziekenhuis Groningen; Medical Oncology, Groningen

6229 HX

Maastricht University Medical Centre; Dermatologie, Maastricht

08036

Hospital Clinic i Provincial; Servicio de Farmacia, Barcelona

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01815840 - A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas | Biotech Hunter | Biotech Hunter